As some of you know, we recently transitioned our Private Label Surgical Instruments from Patterson Veterinary to Pivetal. In doing so, we also changed manufacturing partners which has inevitably disrupted our ability to satisfy the “Lifetime Warranty” of Webster or…
Things are heating up with the Pivetal Transition! We are happy to announce that Pivetal® Meloxidyl (meloxicam) Oral Suspension is now available in all four sizes! Meloxidyl Oral Suspension is an NSAID that is used to reduce pain and inflammation…
Attached is information on a biocabinet line we will carry for use primarily in chemotherapy treatment. There are 3’ & 4’ models, depending on the capacity needed, theyre approx. $1k difference, and come in around $10k and under before installation. …
Please be aware that Nutramax has updated their packaging on Denamarin Advanced Small 120ct (DENAMSM120-ADV) over the past month. Customers will start receiving this new packaging if you haven’t already. The actual product formulation has not changed, just packaging. New…
Merck is excited to announce their Bravecto 1-Month product. Below are the new skus. From Merck – This product is fully approved and customers will be able to start placing orders for the product on 9/1/2020, when the Merck promotion…
Attached is a letter from Jan Cunningham, Dechra’s Director of Regulatory Affairs, North America, explaining the Mirataz®(mirtazapine transdermal ointment) shelf life extension, from 30 months to 48 months, which was approved by FDA in October 2019. The letter includes information…
The U.S. Food and Drug Administration has approved Vetoquinol USA’s Imoxi Topical Solution for Cats, a generic equivalent of Bayer’s Advantage Multi antiparasitic. Imoxi Topical Solution for Cats (imidacloprid and moxidectin) is formulated to prevent heartwormsand treat fleas, ear mites…
Merck Animal Health has reached an agreement with Virbac to acquire the U.S. rights to Sentinel Flavor Tabs (milbemycin oxime/lufenuron) and Sentinel Spectrum Chews (milbemycin oxime/lufenuron/praziquantel) for approximately $400 million, according to a company press release.